Literature DB >> 3871302

Remnant saphenous veins after aortocoronary bypass grafting: analysis of 3,394 centimeters of unused vein from 402 patients.

B F Waller, W C Roberts.   

Abstract

To assess the status of a saphenous vein (SV) excised for coronary artery bypass grafting (CABG), 3,394 cm of remnant SV from 402 patients who underwent CABG were examined. The SV remnants were 0.5 to 52 cm long (mean 8.4). They were sectioned into 5-mm-long segments, and the resulting 6,788 five-millimeter segments were examined histologically: 5,896 (87%) were narrowed 0 to 25% in cross-sectional area by fibrous tissue; 853 (12%) were narrowed 26 to 50%; 23 (0.6%), 51 to 75%, and 16 (0.4%) segments were narrowed 76 to 100%. Of the 16 segments severely narrowed, 7 (44%) were nearly totally occluded by fibrous tissue. In 17 patients who died within 24 hours of CABG, similar degrees of luminal narrowing were observed in remnant segments and in utilized segments of SV. Thus, significant preexisting luminal narrowing of SV used for CABG is infrequent. The intimal fibrous thickening is variable within the same vein when each 5-mm-long segment is analyzed; it is variable from 1 vein to another in the same patient, and it varies among patients.

Entities:  

Mesh:

Year:  1985        PMID: 3871302     DOI: 10.1016/0002-9149(85)90301-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Intimal fibrosis (phlebosclerosis) in the saphenous vein of the lower limb: a quantitative analysis.

Authors:  K Langes; W Hort
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Immunocytochemical features of obstructed saphenous vein coronary artery bypass grafts.

Authors:  J I Brody; N J Pickering; G B Fink
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

3.  William Clifford Roberts, MD: an interview by W. Bruce Fye, MD.

Authors:  William C Roberts; W Bruce Fye
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

4.  Why is the mammary artery so special and what protects it from atherosclerosis?

Authors:  Fumiyuki Otsuka; Kazuyuki Yahagi; Kenichi Sakakura; Renu Virmani
Journal:  Ann Cardiothorac Surg       Date:  2013-07

Review 5.  Vein quality in infrainguinal revascularisation: assessment by angioscopy and histology.

Authors:  Y G Wilson
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

Review 6.  Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis.

Authors:  Kazuyuki Yahagi; Frank D Kolodgie; Fumiyuki Otsuka; Aloke V Finn; Harry R Davis; Michael Joner; Renu Virmani
Journal:  Nat Rev Cardiol       Date:  2015-10-27       Impact factor: 32.419

7.  In Vivo Functional Evaluation of Tissue-Engineered Vascular Grafts Fabricated Using Human Adipose-Derived Stem Cells from High Cardiovascular Risk Populations.

Authors:  Jeffrey T Krawiec; Justin S Weinbaum; Han-Tsung Liao; Aneesh K Ramaswamy; Dominic J Pezzone; Alexander D Josowitz; Antonio D'Amore; J Peter Rubin; William R Wagner; David A Vorp
Journal:  Tissue Eng Part A       Date:  2016-05       Impact factor: 3.845

8.  Versican is differentially regulated in the adventitial and medial layers of human vein grafts.

Authors:  Richard D Kenagy; Shinsuke Kikuchi; Steve P Evanko; Matthijs S Ruiter; Marco Piola; Alban Longchamp; Maurizio Pesce; Monica Soncini; Sébastien Deglise; Gianfranco B Fiore; Jacques-Antoine Haefliger; Tannin A Schmidt; Mark W Majesky; Michael Sobel; Thomas N Wight
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.